1-3 of 3
Rene Van der Griend
Close
Sort by
Journal Articles

Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients:

Jaap Jan Zwaginga, MD, PhD, Ronnie van der Holt, PhD, Bart J. Biemond, MD, PhD, Peter A.W. te Boekhorst, MD, PhD, Mark Levin, MD, PhD, Art Vreughdenhil, MD, PhD, P.C. Huijgens, MD, PhD, Anneke Brand, MD, PhD, Rene van der Griend, MD, PhD, Marleen Luten, Hans Pruijt, MD, PhD, Okke de Weerdt, Elisabeth van Pampus, MD, PhD, Sonja Zweegman, MD, PhD, Rene Hollestein, Harry R. Koene, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2514.
https://doi.org/10.1182/blood.V116.21.2514.2514
Published: 2010
Journal Articles

Out of Hospital Treatment of Acute Pulmonary Embolism in Patients with a Low NT-ProBNP Level.

Mariette J Agterof, MD, Roger E.G. Schutgens, MD, PhD, Repke J Snijder, MD, G. Epping, MD, Henny G Peltenburg, MD, PhD, Ward Posthuma, MD, PhD, J. A. Hardeman, MD, Rene Van der Griend, MD, PhD, Ted Koster, Martin Prins, MD, PhD, Douwe Biesma, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3996.
https://doi.org/10.1182/blood.V114.22.3996.3996
Published: 2009
Journal Articles

Successful Harvesting of Peripheral Hematopoietic Stem Cells after Induction Treatment with Bortezomib, Adriamycin, Dexamethasone (PAD) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Hartmut Goldschmidt, Henk M. Lokhorst, Uta Bertsch, Bronno van der Holt, Laila el Jarari, Hans-Jürgen Salwender, Sonja Zweegman, Edo Vellenga, Jörg Schubert, Igor W. Blau, Asiong Jie, Berna Beverloo, Dirk Hose, Helgi van de Velde, Martyn Ronald Schaafsma, Marie Jose Kersten, Michel Delforge, Okke de Weerdt, Rene Van der Griend, Pierre Wijermans, Hans Martin, Christof Scheid, Mathias Hänel, Ingo G.H. Schmidt-Wolf, Pieter Sonneveld for the HOVON GMMG group
Journal: Blood
Blood (2008) 112 (11): 3470.
https://doi.org/10.1182/blood.V112.11.3470.3470
Published: 2008